Human muscle stem cells

Current Opinion in Pharmacology

Volumn 6, Issue 3, 2006, Pages 295-300

  Cooper, Racquel N ^a   Butler Browne, Gillian S ^a   Mouly, Vincent ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; DESMIN; DYSTROPHIN; MYOD PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR PAX7; TRANSCRIPTION FACTOR RUNX2;

CELL DIFFERENTIATION; CELL DIVISION; CELL POPULATION; CELL PROLIFERATION; CELL SPECIFICITY; CELL TRANSFORMATION; CLINICAL TRIAL; DUCHENNE MUSCULAR DYSTROPHY; EMBRYONIC STEM CELL; GRAFT REJECTION; GRAFT SURVIVAL; HEART FAILURE; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MULTIPOTENT STEM CELL; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SAFETY; SKELETAL MUSCLE SATELLITE CELL; SKULL DEFECT; STEM CELL; STEM CELL TRANSPLANTATION; STROKE;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; HEART DISEASES; HUMANS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; REGENERATION; SATELLITE CELLS, SKELETAL MUSCLE; STEM CELL TRANSPLANTATION;

EID: 33646374146     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2006.01.007     Document Type: Review

References (39)

1. Decary S., Hamida C.B., Mouly V., Barbet J.P., Hentati F., and Butler-Browne G.S. Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children. Neuromuscul Disord 10 (2000) 113-120
2. Heslop L., Morgan J.E., and Partridge T.A. Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J Cell Sci 113 (2000) 2299-2308
3. Cardasis C.A., and Cooper G.W. An analysis of nuclear numbers in individual muscle fibers during differentiation and growth: a satellite cell-muscle fiber growth unit. J Exp Zool 191 (1975) 347-358
4. Bischoff R. The satellite cell and muscle regeneration. In: Engel A.G., and Franzini-Armstrong C. (Eds). Myology Volume 1. edn 2 (1994), McGraw-Hill, Inc, New York 97-118
5. Decary S., Mouly V., Hamida C.B., Sautet A., Barbet J.P., and Butler-Browne G.S. Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapy. Hum Gene Ther 8 (1997) 1429-1438
6. Renault V., Thornell L.E., Eriksson P.O., Butler-Browne G., and Mouly V. Regenerative potential of human skeletal muscle during aging. Aging Cell 1 (2002) 132-139
7. Taylor-Jones J.M., McGehee R.E., Rando T.A., Lecka-Czernik B., Lipschitz D.A., and Peterson C.A. Activation of an adipogenic program in adult myoblasts with age. Mech Ageing Dev 123 (2002) 649-661
8. Collins C.A., Olsen I., Zammit P.S., Heslop L., Petrie A., Partridge T.A., and Morgan J.E. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122 (2005) 289-301. By transplanting freshly isolated single mouse fibres with their resident satellite cells into irradiated host muscles, these authors show that as few as seven satellite cells can generate over 100 new myofibers containing thousands of myonuclei, as well as new satellite cells that can be recruited through subsequent cycles of regeneration. This efficiency is much higher than that observed in any experimental study involving transplantation of cells into skeletal muscle. Whether the isolated fibre contains a more potent progenitor that cannot be isolated in culture, but is maintained within the freshly isolated fibre, is not yet known. Intrerestingly, these results can only be obtained if the mouse recipient muscle has been irradiated prior to the transplantation of the fibre. This set of results opens a new field of research to understand how such an efficiency can be reached, suggesting that cells located at the periphery of the fibres have real stem potential.
9. Deasy B.M., Li Y., and Huard J. Tissue engineering with muscle-derived stem cells. Curr Opin Biotechnol 15 (2004) 419-423
10. Jackson K.A., Mi T., and Goodell M.A. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci USA 96 (1999) 14482-14486
11. Kawada H., and Ogawa M. Hematopoietic progenitors and stem cells in murine muscle. Blood Cells Mol Dis 27 (2001) 605-609
12. McKinney-Freeman S.L., Jackson K.A., Camargo F.D., Ferrari G., Mavilio F., and Goodell M.A. Muscle-derived hematopoietic stem cells are hematopoietic in origin. Proc Natl Acad Sci USA 99 (2002) 1341-1346
13. Gussoni E., Soneoka Y., Strickland C.D., Buzney E.A., Khan M.K., Flint A.F., Kunkel L.M., and Mulligan R.C. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401 (1999) 390-394
14. Asakura A., Seale P., Girgis-Gabardo A., and Rudnicki M.A. Myogenic specification of side population cells in skeletal muscle. J Cell Biol 159 (2002) 123-134
15. Seale P., Sabourin L.A., Girgis-Gabardo A., Mansouri A., Gruss P., and Rudnicki M.A. Pax7 is required for the specification of myogenic satellite cells. Cell 102 (2000) 777-786
16. Gussoni E., Blau H.M., and Kunkel L.M. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med 3 (1997) 970-977
17. Torrente Y., Tremblay J.P., Pisati F., Belicchi M., Rossi B., Sironi M., Fortunato F., El Fahime M., D'Angelo M.G., Caron N.J., et al. Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J Cell Biol 152 (2001) 335-348
18. Qu-Petersen Z., Deasy B., Jankowski R., Ikezawa M., Cummins J., Pruchnic R., Mytinger J., Cao B., Gates C., Wernig A., et al. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 157 (2002) 851-864
19. Teboul L., Gaillard D., Staccini L., Inadera H., Amri E.Z., and Grimaldi P.A. Thiazolidinediones and fatty acids convert myogenic cells into adipose-like cells. J Biol Chem 270 (1995) 28183-28187
20. Asakura A., Komaki M., and Rudnicki M. Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 68 (2001) 245-253
21. Wada M.R., Inagawa-Ogashiwa M., Shimizu S., Yasumoto S., and Hashimoto N. Generation of different fates from multipotent muscle stem cells. Development 129 (2002) 2987-2995
22. Vertino A.M., Taylor-Jones J.M., Longo K.A., Bearden E.D., Lane T.F., McGehee Jr. R.E., MacDougald O.A., and Peterson C.A. Wnt10b deficiency promotes coexpression of myogenic and adipogenic programs in myoblasts. Mol Biol Cell 16 (2005) 2039-2048
23. Qu Z., Balkir L., van Deutekom J.C., Robbins P.D., Pruchnic R., and Huard J. Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 142 (1998) 1257-1267
24. Lee J.Y., Qu-Petersen Z., Cao B., Kimura S., Jankowski R., Cummins J., Usas A., Gates C., Robbins P., Wernig A., et al. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 150 (2000) 1085-1100
25. Cao B., Zheng B., Jankowski R.J., Kimura S., Ikezawa M., Deasy B., Cummins J., Epperly M., Qu-Petersen Z., and Huard J. Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential. Nat Cell Biol 5 (2003) 640-646
26. Alessandri G., Pagano S., Bez A., Benetti A., Pozzi S., Iannolo G., Baronio M., Invernici G., Caruso A., Muneretto C., et al. Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineages. Lancet 364 (2004) 1872-1883
27. Schultz S.S., and Lucas P.A. Human stem cells isolated from adult skeletal muscle differentiate into neural phenotypes. J Neurosci Methods 152 (2005) 144-155
28. Ferrari G., Cusella-De Angelis G., Coletta M., Paolucci E., Stornaiuolo A., Cossu G., and Mavilio F. Muscle regeneration by bone marrow derived myogenic progenitors. Science 279 (1998) 1528-1530
29. Ferrari G., Stornaiuolo A., and Mavilio F. Failure to correct murine muscular dystrophy. Nature 411 (2001) 1014-1015
30. Corbel S.Y., Lee A., Yi L., Duenas J., Brazelton T.R., Blau H.M., and Rossi F.M. Contribution of hematopoietic stem cells to skeletal muscle. Nat Med 9 (2003) 1528-1532
31. Sampaolesi M., Torrente Y., Innocenzi A., Tonlorenzi R., D'Antona G., Pellegrino M.A., Barresi R., Bresolin N., De Angelis M.G., Campbell K.P., et al. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 301 (2003) 487-492
32. Torrente Y., Belicchi M., Sampaolesi M., Pisati F., Meregalli M., D'Antona G., Tonlorenzi R., Porretti L., Gavina M., Mamchaoui K., et al. Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Invest 114 (2004) 182-195
33. Rodriguez A.M., Pisani D., Dechesne C.A., Turc-Carel C., Kurzenne J.Y., Wdziekonski B., Villageois A., Bagnis C., Breittmayer J.P., Groux H., et al. Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J Exp Med 201 (2005) 1397-1405
34. Mueller G.M., O'Day T., Watchko J.F., and Ontell M. Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice. Hum Gene Ther 13 (2002) 1081-1090
35. Beauchamp J.R., Morgan J.E., Pagel C.N., and Partridge T.A. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol 144 (1999) 1113-1122
36. Negroni E., Butler-Browne G.S., and Mouly V. Myogenic stem cells: regeneration and cell therapy in human skeletal muscle. Pathol Biol (2005)
37. Menasché P., Hagege A.A., Scorsin M., Pouzet B., Desnos M., Duboc D., Schwartz K., Vilquin J.T., and Marolleau J.P. Myoblast transplantation for heart failure. Lancet 357 (2001) 279-280
38. Vilquin J.T., Marolleau J.P., Sacconi S., Garcin I., Lacassagne M.N., Robert I., Ternaux B., Bouazza B., Larghero J., and Desnuelle C. Normal growth and regenerating ability of myoblasts from unaffected muscles of facioscapulohumeral muscular dystrophy patients. Gene Ther. 12 (2005) 1651-1662
39. 4 freshly isolated cells, sorted by FACS using the same characteristics, showed that these freshly isolated cells were 10-50 times more efficient than myogenic cells expanded in culture. These data can be explained either by the presence of a population of cells that is lost during expansion in culture, or by modifications of the cells during the expansion in vitro.